On Monday, IGC Pharma Inc (AMEX: IGC) was -4.03% drop from the session before settling in for the closing price of $0.36. A 52-week range for IGC has been $0.26 – $0.91.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
It was noted that within the last five years, the titan of the Healthcare sector saw sales topped by 4.59%. When this article was written, the company’s average yearly earnings per share was at 50.00%. With a float of $53.25 million, this company’s outstanding shares have now reached $76.64 million.
The extent of productivity of a business whose workforce counts for 67 workers is very important to gauge. In terms of profitability, gross margin is 44.38%, operating margin of -788.17%, and the pretax margin is -1062.47%.
IGC Pharma Inc (IGC) Insider and Institutional Ownership
Also, it is sometimes useful to examine the sentiment of large-scale investors toward IGC Pharma Inc stocks. The insider ownership of IGC Pharma Inc is 31.25%, while institutional ownership is 3.62%. The most recent insider transaction that took place on Sep 25 ’24, was worth 200,000. In this transaction Director of this company bought 588,235 shares at a rate of $0.34, taking the stock ownership to the 942,402 shares. Before that another transaction happened on Aug 12 ’24, when Company’s Director proposed sale 200,000 for $0.39, making the entire transaction worth $78,200.
IGC Pharma Inc (IGC) Latest Financial update
Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.03 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 50.00% per share during the next fiscal year.
IGC Pharma Inc (AMEX: IGC) Trading Performance Indicators
You can see what IGC Pharma Inc (IGC) is doing with its current performance indicators. In the most recent quarter, the stock posted a quick ratio of 0.91. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 22.48.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -0.19, a number that is poised to hit -0.03 in the next quarter and is forecasted to reach -0.12 in one year’s time.
Technical Analysis of IGC Pharma Inc (IGC)
The latest stats from [IGC Pharma Inc, IGC] show that its last 5-days average volume of 0.48 million was superior to 0.44 million than last year’s volume. As of the previous 9 days, the stock’s Stochastic %D was 42.00%. Additionally, its Average True Range was 0.03.
During the past 100 days, IGC Pharma Inc’s (IGC) raw stochastic average was set at 8.40%, which indicates a significant decrease from 16.11% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 66.55% in the past 14 days, which was higher than the 59.57% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $0.3705, while its 200-day Moving Average is $0.4215. Now, the first resistance to watch is $0.3539. This is followed by the second major resistance level at $0.3653. The third major resistance level sits at $0.3709. If the price goes on to break the first support level at $0.3369, it is likely to go to the next support level at $0.3313. The third support level lies at $0.3199 if the price breaches the second support level.
IGC Pharma Inc (AMEX: IGC) Key Stats
There are 77,449K outstanding shares of the company, which has a market capitalization of 26.53 million. As of now, sales total 1,350 K while income totals -13,000 K. Its latest quarter income was 410 K while its last quarter net income were -1,720 K.
